ATXS icon

Astria Therapeutics
ATXS

Overview Fund Trends Analyst Outlook Journalist POV

33 hedge funds and large institutions have $81.4M invested in Astria Therapeutics in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
33
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.25M
2
+$307K
3
+$238K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$140K
5
DM
Deerfield Management
New York
+$119K

Top Sellers

1
-$1.96M
2
-$325K
3
-$302K
4
UBS Group
UBS Group
Switzerland
-$176K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$103K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$11K
27
$8K
28
$5.79K
29
$4K
30
$3K
31
$2K
32
$1K
33
$1K
34
–
35
–
36
–
37
–
38
–
39
–
1
2